Relyvrio Side Effects

Generic name: sodium phenylbutyrate / taurursodiol

Medically reviewed by Drugs.com. Last updated on Jan 17, 2024.

Note: This document provides detailed information about Relyvrio.

Applies to sodium phenylbutyrate / taurursodiol: oral powder for suspension Side Effects associated with sodium phenylbutyrate / taurursodiol. Some dosage forms listed on this page may not apply specifically to the brand name Relyvrio.

Applies to sodium phenylbutyrate / taurursodiol: oral powder for suspension.

Precautions

Your doctor will check your progress closely while you are using this medicine to see if the medicine is working properly and to check for unwanted effects.

Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.

Serious side effects of Relyvrio

Along with its needed effects, sodium phenylbutyrate/taurursodiol may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking sodium phenylbutyrate / taurursodiol:

Other side effects of Relyvrio

Some side effects of sodium phenylbutyrate / taurursodiol may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

For healthcare professionals

Applies to sodium phenylbutyrate / taurursodiol: oral powder for reconstitution.

General adverse events

The most common adverse reactions were diarrhea, abdominal pain, nausea, and upper respiratory tract infection. While gastrointestinal side effects occurred throughout the study duration, they were more common in the first three weeks of treatment.^[Ref]

Gastrointestinal

• Very common (10% or more): Abdominal pain (21%), diarrhea (25%), nausea (18%), salivary hypersecretion (11%)^[Ref]

Nervous system

• Common (1% to 10%): Dizziness^[Ref]

Other

• Very common (10% or more): Fatigue (12%)^[Ref]

Respiratory

• Very common (10% or more): Upper respiratory tract infection (18%)^[Ref]

See also:

Further information

Relyvrio side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer